Recherche
-
Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis.
(Frontiers in Pharmacology. vol. 14, pp. 1129244, 2023-05-15)Article de revueLibre accès -
Analgesic switching in chronic users of dextropropoxyphene in France
(Fundamental & Clinical Pharmacology, 2023-10-21)Article de revueLibre accès -
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: a case report
(Pain Practice. vol. 23, n° 2, pp. 216-219, 2023-02)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 12, pp. 769315, 2021-10-28)Article de revueLibre accès -
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
(Cancers. vol. 14, n° 21, 2022-10-28)Article de revueLibre accès -
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
(Pharmaceuticals (Basel). vol. 17, n° 3, 2024-03-06)Article de revueLibre accès -
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study
(Clinical Genitourinary Cancer. vol. 22, n° 2, pp. 295-304, 2023-11-24)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès